Skip to content

We are supported by referral fees from the advertisers presented on this site. We do not present information about every advertiser or offer available.

Semaglutide.now
Semaglutide

Refills vs bmiMD: Flat $99 GLP-1 or multi-month tirzepatide plans

Quick verdict: Refills vs bmiMD pits Refills’ flat-price, month-to-month compounded GLP-1 from $99/month against bmiMD’s compounded tirzepatide with multi-month pricing down to $139/month. If you want the simplest month-to-month price, Refills is the clear choice; if you prefer tirzepatide with lower long-term monthly equivalents tied to commitments, bmiMD may fit better.

Start Refills $99/mo plan

Refills vs bmiMD at a glance

This comparison focuses on five main differences supported by the source material: starting price and pricing model, medication options, billing commitments and long-term pricing, shipping and clinician access, and regulatory status of compounded medications. The primary keyword Refills vs bmiMD is used to compare these points directly.

1. Starting price and pricing model

Refills advertises personalized compounded GLP-1 from $99/month (~$5/day) with flat pricing, the same price at every dosage, and no titration upcharges. bmiMD lists tirzepatide pricing that ranges by plan: $179/month for monthly, $159/month for three-month, $149/month for six-month, and $139/month for a 12-month plan, with the lowest price requiring a 12-month commitment.

View bmiMD tirzepatide plans

2. Medication options and formulation

Refills offers semaglutide and tirzepatide and notes availability of a GIP+GLP-1 dual agonist, with an explicit mention that compounded medications may be prescribed where deemed medically appropriate. bmiMD focuses on compounded tirzepatide (GLP-1/GIP) as its highlighted product. Both providers reference compounded products in their descriptions.

3. Billing commitments and long-term pricing

Refills presents a month-to-month plan with no membership or app fees and the ability to cancel anytime, emphasizing no contracts or cancellation fees. bmiMD advertises multiple billing options where the lowest monthly equivalent requires longer commitments and a total prepaid charge should be confirmed, and it notes four billing options including 1, 3, 6, and 12 month plans.

Choose Refills month-to-month

4. Shipping, turnaround, and clinician access

Both providers offer free shipping on subscription orders. Refills promises free discreet shipping, express shipping, and 24/7 health concierge support with licensed clinician review after a health intake quiz and shipment tracking in 2 business days. bmiMD advertises free subscription shipping and 24/7 clinician access and describes timely turnaround and delivery from state-licensed pharmacies verified in labs.

5. Regulatory and safety notes

Both sources clearly state that compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA. Refills repeats that compounded medications are not FDA-approved and notes that compounding pharmacies are licensed and inspected by Boards of Pharmacy. bmiMD also states that compounded medications, when offered, are not FDA-approved and not reviewed by FDA for safety, effectiveness, or quality.

Comparison table: Refills vs bmiMD

Criteria Refills bmiMD
Starting price $99/month (~$5/day) for GLP-1 $179/month monthly; down to $139/month with 12-month plan
Pricing model Flat pricing, same price at every dosage; month-to-month Multi-month options with lower long-term monthly equivalent
Medications offered Semaglutide, Tirzepatide, GIP+GLP-1 dual agonist available Compounded Tirzepatide (GLP-1/GIP)
Shipping and support Free discreet shipping, express shipping, 24/7 health concierge Free subscription shipping, 24/7 clinician access
Commitment and cancellation Month-to-month; cancel anytime; no contracts or cancellation fees Lowest monthly price requires 12-month commitment; total charge should be confirmed
Regulatory note Compounded medications not FDA-evaluated; pharmacies licensed and inspected Compounded medications not FDA-evaluated

How the differences matter

Price sensitivity: If you prioritize the lowest up-front monthly price without commitment, Refills’ $99/mo flat pricing is the differentiator. If you plan to commit longer and want tirzepatide specifically, bmiMD’s multi-month tiers can lower the monthly equivalent but require confirming the total prepaid charge.

Medication preference: Refills lists semaglutide and tirzepatide plus a GIP+GLP-1 dual agonist option; bmiMD highlights compounded tirzepatide. Choose based on which active medication you expect to pursue and whether compounded status is acceptable to you.

Support and logistics: Both vendors offer free shipping and clinician access around the clock, but Refills emphasizes a 24/7 health concierge, express shipping, and a month-to-month workflow that includes refill forms and clinician consultations at no extra cost.

Check bmiMD multi-month options

Compare Refills offerings

Conclusion: Choose based on price model and medication

Refills vs bmiMD shows a clear split: Refills prioritizes flat, month-to-month pricing from $99/month with no membership or app fees and free discreet shipping, while bmiMD centers on compounded tirzepatide with multi-month plans that reduce the monthly equivalent to as low as $139/month but require longer commitments. Both note that compounded medications are not FDA-approved.

Choose Refills if you want a simple month-to-month price, flat pricing at every dosage, free discreet shipping, and 24/7 health concierge support. Choose bmiMD if you specifically want compounded tirzepatide and are willing to confirm a multi-month plan to obtain a lower long-term monthly equivalent.

Primary keyword: Refills vs bmiMD

Ready to Compare GLP-1 Providers?

Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.

Compare All Providers →

Leave a comment

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment.